The use of oral sulfonylurea drugs in pregnant women has been limited, and therefore there is scant information on their efficacy. 2–4 The available data are from retrospective studies of small ...

Antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac) or sertraline (Zoloft), ...

Sulfonylureas are a class of diabetes medications used to help control blood sugar levels. Magnesium can increase the ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...

The sulfonylureas remain one of the mainstays in the management of type 2 diabetes and are the most commonly used oral antidiabetic medications. [8, 11] Not surprisingly, overdose with ...

Rheumatoid arthritis drugs fight pain and prevent joint damage. See a full list of RA medications, including NSAIDs, DMARDs, immunosuppressants, and others.

Though rare, these drugs can cause serious kidney damage, especially in people with preexisting kidney disease. Doctors usually avoid giving these medicines to patients with abnormal kidney function.

These Diabetes Drugs Are Finding New Life as an Antiaging Hack Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer By ...

A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial ...